story of the week
PNPLA3 rs738409, Age, Diabetes, Sex, and Advanced Fibrosis Jointly Contribute to the Risk of Major Adverse Liver Outcomes in Patients With MASLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease
Hepatology 2024 Nov 01;80(5)1212-1226, N Chalasani, E Vilar-Gomez, R Loomba, KP Yates, AM Diehl, BA Neuschwander-Tetri, S Dasarathy, KV Kowdley, N Terrault, LA Wilson, J Tonascia, AJ SanyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.